Literature DB >> 1738786

Do autoreceptors mediate dopamine agonist--induced yawning and suppression of exploration? A critical review.

L Ståhle1.   

Abstract

The hypothesis that stimulation of dopamine autoreceptors is the mechanism by which dopamine agonists induce yawning and suppression of exploration is critically examined. It is shown that the relation between reduced extracellular dopamine levels, assessed by microdialysis, and behavioural effects of dopamine agonists, a dopamine synthesis inhibitor and a granule storage blocker is highly inconsistent. The time-course and duration of the behavioural effects of dopamine agonists differ from the reduction of extracellular dopamine. Amphetamine cotreatment is shown to increase dopamine levels, while yawning and suppression of exploration can still be induced. The data strongly indicate that autoreceptors are not the mediators of these behavioural effects. It is proposed that postsynaptic receptors mediate dopamine agonist induced yawning and suppression of exploration. Evidence is also presented showing that yawning and suppression of exploration are not functionally equivalent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738786     DOI: 10.1007/bf02253581

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

1.  Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following alpha-methyltyrosine or reserpine.

Authors:  H Wachtel; S Ahlenius; N E Andén
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

2.  Evidence for dopamine receptors in the human brain mediating sedation and sleep.

Authors:  G U Corsini; M Del Zompo; S Manconi; M P Piccardi; P L Onali; A Mangoni
Journal:  Life Sci       Date:  1977-05-01       Impact factor: 5.037

Review 3.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

4.  Automatic registration of behaviour related to dopamine and noradrenaline transmission.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1976-03       Impact factor: 4.432

5.  Dopamine"autoreceptors": pharmacological characterization by microiontophoretic single cell recording studies.

Authors:  G K Aghajanian; B S Bunney
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

6.  Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.

Authors:  M J Bannon; E B Bunney; R H Roth
Journal:  Brain Res       Date:  1981-08-10       Impact factor: 3.252

7.  Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis.

Authors:  T Zetterström; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1984-01-13       Impact factor: 4.432

8.  Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.

Authors:  J Lehmann; M Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1983-03-18       Impact factor: 4.432

9.  Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.

Authors:  C T Dourish; S J Cooper; S R Philips
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats.

Authors:  K Yamada; M Tanaka; K Shibata; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

View more
  10 in total

1.  Pathological yawning as a symptom of multiple sclerosis.

Authors:  T Postert; D Pöhlau; S Meves; I Nastos; H Przuntek
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

2.  The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity.

Authors:  N Waters; K Svensson; S R Haadsma-Svensson; M W Smith; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1993

3.  Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats.

Authors:  A Guyon; F Assouly-Besse; G Biala; A J Puech; M H Thiébot
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Divergent effect of the selective D3 receptor agonist pd-128,907 on locomotor activity in Roman high- and low-avoidance rats: relationship to NGFI-A gene expression in the Calleja islands.

Authors:  Marc Guitart-Masip; Björn Johansson; Albert Fernández-Teruel; Adolf Tobeña; Lydia Giménez-Llort
Journal:  Psychopharmacology (Berl)       Date:  2007-10-19       Impact factor: 4.530

5.  Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour.

Authors:  N Waters; L Löfberg; S Haadsma-Svensson; K Svensson; C Sonesson; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1994

6.  Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release.

Authors:  K Svensson; A Carlsson; N Waters
Journal:  J Neural Transm Gen Sect       Date:  1994

7.  Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats.

Authors:  K J Frantz; C Van Hartesveldt
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

8.  Dopamine agonists facilitate footshock-elicited locomotion in rats, and suppress level-press responding for food.

Authors:  S R Franklin; A H Tang
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

9.  Aripiprazole (OPC-14597) fully substitutes for the 5-HT1A receptor agonist LY293284 in the drug discrimination assay in rats.

Authors:  Danuta Marona-Lewicka; David E Nichols
Journal:  Psychopharmacology (Berl)       Date:  2003-11-28       Impact factor: 4.530

10.  Role of dopamine receptors in the dual effect of naloxone on quinpirole-induced yawning in morphine pretreated rats.

Authors:  A Zharkovsky; J Moisio; T Kivastik; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.